期刊文献+

Hepatocellular carcinoma: Review of disease and tumor biomarkers 被引量:13

Hepatocellular carcinoma: Review of disease and tumor biomarkers
下载PDF
导出
摘要 Hepatocellular carcinoma(HCC) is a common malignancy and now the second commonest global cause of cancer death. HCC tumorigenesis is relatively silent and patients experience late symptomatic presentation. As the option for curative treatments is limited to early stage cancers, diagnosis in non-symptomatic individuals is crucial. International guidelines advise regular surveillance of high-risk populations but the current tools lack sufficient sensitivity for early stage tumors on the background of a cirrhotic nodular liver. A number of novel biomarkers have now been suggested in the literature, which may reinforce the current surveillance methods. In addition, recent metabonomic and proteomic discoveries have established specific metabolite expressions in HCC, according to Warburg's phenomenon of altered energy metabolism. With clinical validation, a simple and non-invasive test from the serum or urine may be performed to diagnose HCC, particularly benefiting low resource regions where the burden of HCC is highest. Hepatocellular carcinoma(HCC) is a common malignancy and now the second commonest global cause of cancer death. HCC tumorigenesis is relatively silent and patients experience late symptomatic presentation. As the option for curative treatments is limited to early stage cancers, diagnosis in non-symptomatic individuals is crucial. International guidelines advise regular surveillance of high-risk populations but the current tools lack sufficient sensitivity for early stage tumors on the background of a cirrhotic nodular liver. A number of novel biomarkers have now been suggested in the literature, which may reinforce the current surveillance methods. In addition, recent metabonomic and proteomic discoveries have established specific metabolite expressions in HCC, according to Warburg's phenomenon of altered energy metabolism. With clinical validation, a simple and non-invasive test from the serum or urine may be performed to diagnose HCC, particularly benefiting low resource regions where the burden of HCC is highest.
出处 《World Journal of Hepatology》 CAS 2016年第10期471-484,共14页 世界肝病学杂志(英文版)(电子版)
关键词 HEPATOCELLULAR carcinoma BIOMARKER METABONOMICS WARBURG HYPOTHESIS Serum Plasma URINE Hepatocellular carcinoma Biomarker Metabonomics Warburg hypothesis Serum Plasma Urine
  • 相关文献

参考文献53

  • 1Geng-WenHuang Lian-YueYang Wei-QunLu.Expression of hypoxia-inducible factor la and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival[J].World Journal of Gastroenterology,2005,11(11):1705-1708. 被引量:51
  • 2Lin Zhou,Jia Liu,Feng Luo.Serum tumor markers for detection of hepatocellular carcinoma[J].World Journal of Gastroenterology,2006,12(8):1175-1181. 被引量:78
  • 3N. F. LaRusso,N. E. Hoffman,M. G. Korman,A. F. Hofmann,A. E. Cowen.??Determinants of fasting and postprandial serum bile acid levels in healthy man(J)The American Journal of Digestive Diseases . 1978 (5)
  • 4Morris Sherman,Kevork M. Peltekian,Cindy Lee.??Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: Incidence and prevalence of hepatocellular carcinoma in a North American urban population(J)Hepatology . 1995 (2)
  • 5Simon D Taylor-Robinson,Graham R Foster,Shona Arora,Sally Hargreaves,Howard C Thomas.??Increase in primary liver cancer in the UK, 1979–94(J)The Lancet . 1997 (9085)
  • 6Josep Llovet,Concepció Brú,Jordi Bruix.Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification[J].Semin Liver Dis.1999(03)
  • 7Takashi Kumada,Satoshi Nakano,Isao Takeda,Seiki Kiriyama,Yasuhiro Sone,Kazuhiko Hayashi,Hiromasa Katoh,Tomonori Endoh,Toshi Sassa,Shinji Satomura.??Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis(J)Journal of Hepatology . 1999 (1)
  • 8Rodolfo Sacco,Domenico Leuci,Cosimo Tortorella,Giorgio Fiore,Felice Marinosci,Salvatore Antonaci.??TRANSFORMING GROWTH FACTOR β1 AND SOLUBLE FAS SERUM LEVELS IN HEPATOCELLULAR CARCINOMA(J)Cytokine . 2000 (6)
  • 9Oliver Fiehn.Combining Genomics, Metabolome Analysis, and Biochemical Modelling to Understand Metabolic Networks[J].Comparative and Functional Genomics.2001(3)
  • 10Jun Akiba,Hirohisa Yano,Sachiko Ogasawara,Koichi Higaki,M. Kojiro.Expression and function of interleukin-8 in human hepatocellular carcinoma[J].International Journal of Oncology.2001(2)

二级参考文献28

共引文献284

同被引文献83

引证文献13

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部